| PERIOD ENDING | 5-Sep-09 | 13-Jun-09 | 21-Mar-09 | 27-Dec-08 | | Total Revenue | 3,633,000 | 3,274,000 | 2,507,000 | 3,809,000 | | Cost of Revenue | 2,012,000 | 1,830,000 | 1,403,000 | 2,111,000 | | | Gross Profit | 1,621,000 | 1,444,000 | 1,104,000 | 1,698,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,185,000 | 1,135,000 | 987,000 | 1,550,000 | | Non Recurring |
-
|
-
|
-
| 412,000 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 436,000 | 309,000 | 117,000 | (264,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 11,000 | (7,000) | (26,000) | | Earnings Before Interest And Taxes | 436,000 | 320,000 | 110,000 | (274,000) | | Interest Expense | 67,000 | 69,000 | 79,000 | 103,000 | | Income Before Tax | 369,000 | 251,000 | 31,000 | (377,000) | | Income Tax Expense | 59,000 | 13,000 | (27,000) | (106,000) | | Minority Interest | 28,000 | (28,000) |
-
| 16,000 | | | | Net Income From Continuing Ops | 338,000 | 210,000 | 58,000 | (271,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 338,000 | 210,000 | 58,000 | (271,000) | | Preferred Stock And Other Adjustments | (84,000) | 1,000 | (1,000) |
-
| | | Net Income Applicable To Common Shares | $254,000 | $211,000 | $57,000 | ($271,000) |
|
2.03% Nasdaq 
Income Statement
